Skip to main content

Advertisement

SpringerLink
Log in

Comparison of Four Risk Prediction Models for Diabetes Remission after Roux-en-Y Gastric Bypass Surgery in Obese Chinese Patients with Type 2 Diabetes Mellitus

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Roux-en-Y gastric bypass (RYGB) is a major type of bariatric surgery. Various models have been established for facilitating clinical decision-making and predicting outcomes after RYGB; the ABCD, DiaRem, advanced-DiaRem (Ad-DiaRem), and DiaBetter scores are among the most commonly used risk prediction models. However, these models were primarily developed based on retrospective analyses of patients from Western countries at 1 year after RYGB. The present study was to assess the performance of these models and identify the optimal model, for predicting postoperative diabetes remission in diabetic Chinese patients.

Methods

The present study included a total of 253 RYGB patients; 214 completed a 1-year follow-up and 131 completed a 3-year follow-up. The assessments and comparisons of the predictive performance of the four models were based on both discrimination and calibration measures. Discrimination was assessed according to the area under the receiver operating characteristic curve (AUC), and calibration was evaluated by Hosmer-Lemeshow goodness-of-fit tests and predicted-to-observed ratios.

Results

One hundred thirteen (52.8%) in the 1-year follow-up group and 59 (45.0%) in the 3-year follow-up group achieved complete diabetes remission. Although all models showed similar discriminatory capacity and good calibration, the DiaBetter model exhibited the best predictive performance (1-year follow-up, AUC 0.760, 95% confidence interval [CI] 0.697–0.815, predicted-to-observed ratio 1.04; 3-year follow-up, AUC 0.804, 95% CI 0.726–0.868, predicted-to-observed ratio 0.95).

Conclusions

The present results indicated that the DiaBetter model is the optimal model for predicting postoperative diabetes remission in diabetic Chinese individuals, due to its excellent predictive accuracy and ready availability for use in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

T2DM:

Type 2 diabetes mellitus

RYGB:

Roux-en-Y gastric bypass

Ad-DiaRem:

Advanced-DiaRem score

SD:

Standard deviation

IQR:

Interquartile range

CI:

Confidence interval

BMI:

Body mass index

AST:

Aspartate aminotransferase

ALT:

Alanine aminotransferase

BUN:

Blood urea nitrogen

TG:

Triglycerides

TC:

Total cholesterol

HDL-c:

High-density lipoprotein cholesterol

LDL-c:

Low-density lipoprotein cholesterol

FPG:

Fasting plasma glucose

PPG:

Postprandial plasma glucose

HbA1c:

Hemoglobin A1c

HOMA-IR:

Homeostasis model of assessment for insulin resistance

PPV:

Positive predictive value

NPV:

Negative predictive value

AUC:

Area under receiver operating characteristic curve

ROC curve:

The receiver operating characteristic (ROC) curve

References

  1. Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and Prediabetes in China in 2013. JAMA. 2017;317(24):2515–23.

    Article  Google Scholar 

  2. Professional Practice Committee: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S3.

  3. Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39(6):861–77.

    Article  CAS  Google Scholar 

  4. Lee WJ, Hur KY, Lakadawala M, et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 2013;9(3):379–84.

    Article  Google Scholar 

  5. Still CD, Wood GC, Benotti P, et al. Preoperative prediction of type 2 diabetes remission after roux-en-Y gastric bypass surgery: a retrospective cohort study. Lancet Diabetes Endocrinol. 2014;2(1):38–45.

    Article  Google Scholar 

  6. Aron-Wisnewsky J, Sokolovska N, Liu Y, et al. The advanced-DiaRem score improves prediction of diabetes remission 1 year post-roux-en-Y gastric bypass. Diabetologia. 2017;60(10):1892–902.

    Article  Google Scholar 

  7. Pucci A, Tymoszuk U, Cheung WH, et al. Type 2 diabetes remission 2 years post roux-en-Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores. Diabet Med. 2018;35(3):360–7.

    Article  CAS  Google Scholar 

  8. Zhang R, Borisenko O, Telegina I, et al. Systematic review of risk prediction models for diabetes after bariatric surgery. Br J Surg. 2016;103(11):1420–7.

    Article  CAS  Google Scholar 

  9. Debedat J, Sokolovska N, Coupaye M, et al. Long-term relapse of type 2 diabetes after roux-en-Y gastric bypass: prediction and clinical relevance. Diabetes Care. 2018;41(10):2086–95.

    Article  CAS  Google Scholar 

  10. Shen SC, Wang W, Tam KW, et al. Validating risk prediction models of diabetes remission after sleeve gastrectomy. Obes Surg. 2019;29(1):221–9.

    Article  Google Scholar 

  11. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5.

    Article  Google Scholar 

  12. Yu H, Li Q, Zhang M, et al. Decreased Leptin is associated with alterations in thyroid-stimulating hormone levels after roux-en-Y gastric bypass surgery in obese euthyroid patients with type 2 diabetes. Obes Facts. 2019;12(3):272–80.

    Article  CAS  Google Scholar 

  13. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36.

    Article  CAS  Google Scholar 

  14. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–5.

    Article  CAS  Google Scholar 

  15. Hosmer DW, Hosmer T, Le Cessie S, et al. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med. 1997;16(9):965–80.

    Article  CAS  Google Scholar 

  16. Chan J, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301(20):2129–40.

    Article  CAS  Google Scholar 

  17. Lee WJ, Chong K, Chen SC, et al. Preoperative prediction of type 2 diabetes remission after gastric bypass surgery: a comparison of DiaRem scores and ABCD scores. Obes Surg. 2016;26(10):2418–24.

    Article  Google Scholar 

  18. Cotillard A, Poitou C, Duchateau-Nguyen G, et al. Type 2 diabetes remission after gastric bypass: what is the best prediction tool for clinicians? Obes Surg. 2015;25(7):1128–32.

    Article  Google Scholar 

  19. Craig Wood G, Horwitz D, Still CD, et al. Performance of the DiaRem score for predicting diabetes remission in two health systems following bariatric surgery procedures in Hispanic and non-Hispanic white patients. Obes Surg. 2018;28(1):61–8.

    Article  CAS  Google Scholar 

  20. Honarmand K, Chetty K, Vanniyasingam T, et al. Type 2 diabetes remission rates 1-year post-roux-en-Y gastric bypass and validation of the DiaRem score: the Ontario bariatric network experience. Clin Obes. 2017;7(3):176–82.

    Article  CAS  Google Scholar 

  21. Stallard R, Sahai V, Drover JW, et al. Defining and using preoperative predictors of diabetic remission following bariatric surgery. JPEN J Parenter Enteral Nutr. 2018;42(3):573–80.

    PubMed  Google Scholar 

  22. Dicker D, Golan R, Aron-Wisnewsky J, et al. Prediction of long-term diabetes remission after RYGB, sleeve gastrectomy, and adjustable gastric banding using DiaRem and advanced-DiaRem scores. Obes Surg. 2019;29(3):796–804.

    Article  Google Scholar 

  23. Aminian A, Brethauer SA, Kashyap SR, et al. DiaRem score: external validation. Lancet Diabetes Endocrinol. 2014;2(1):12–3.

    Article  Google Scholar 

  24. Sampaio-Neto J, Nassif LS, Branco-Filho AJ, et al. External validation of the Diarem score as remission predictor of diabetes mellitus type 2 in obese patients undergoing roux-en-Y gastric bypass. Arq Bras Cir Dig. 2015;28(Suppl 1):19–22.

    Article  Google Scholar 

  25. Tharakan G, Scott R, Szepietowski O, et al. Limitations of the DiaRem score in predicting remission of diabetes following roux-en-Y gastric bypass (RYGB) in an ethnically diverse population from a single institution in the UK. Obes Surg. 2017;27(3):782–6.

    Article  Google Scholar 

Download references

Funding

This study was supported by grants from National Key Research and Development Project of China (2016YFA0502003), National Natural Science Foundation of China (81500625), and Municipal Natural Science Foundation of Shanghai (17ZR1421200).

Author information

Author notes

  1. HoiMan Kam and Yinfang Tu contributed equally to this work.

Authors and Affiliations

  1. Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai Diabetes Institute, Shanghai Clinical Center of Diabetes, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, 200233, China

    HoiMan Kam, Yinfang Tu, Jiemin Pan, Junfeng Han, Yuqian Bao & Haoyong Yu

  2. Department of General Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, 200233, China

    Pin Zhang

Authors
  1. HoiMan Kam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yinfang Tu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiemin Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Junfeng Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuqian Bao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Haoyong Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yuqian Bao or Haoyong Yu.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethnical Approval

This study was approved by the sixth People’s Hospital Ethics Committee of Shanghai Jiaotong University and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Statements of Ethics

According to the World Medical Association’s statement, this study was approved by the Sixth People’s Hospital Ethics Committee of Shanghai Jiaotong University and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All participants received informed written consent before the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kam, H., Tu, Y., Pan, J. et al. Comparison of Four Risk Prediction Models for Diabetes Remission after Roux-en-Y Gastric Bypass Surgery in Obese Chinese Patients with Type 2 Diabetes Mellitus. OBES SURG 30, 2147–2157 (2020). https://doi.org/10.1007/s11695-019-04371-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-019-04371-9

Keywords

Search

Navigation